Glanbia PLC
ISEQ:GL9

Watchlist Manager
Glanbia PLC Logo
Glanbia PLC
ISEQ:GL9
Watchlist
Price: 14.75 EUR 1.37% Market Closed
Market Cap: 3.8B EUR
Have any thoughts about
Glanbia PLC?
Write Note

Intrinsic Value

The intrinsic value of one GL9 stock under the Base Case scenario is 18.58 EUR. Compared to the current market price of 14.75 EUR, Glanbia PLC is Undervalued by 21%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GL9 Intrinsic Value
18.58 EUR
Undervaluation 21%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Glanbia PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for GL9 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about GL9?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Glanbia PLC

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Glanbia PLC

Provide an overview of the primary business activities
of Glanbia PLC.

What unique competitive advantages
does Glanbia PLC hold over its rivals?

What risks and challenges
does Glanbia PLC face in the near future?

Summarize the latest earnings call
of Glanbia PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Glanbia PLC.

Provide P/S
for Glanbia PLC.

Provide P/E
for Glanbia PLC.

Provide P/OCF
for Glanbia PLC.

Provide P/FCFE
for Glanbia PLC.

Provide P/B
for Glanbia PLC.

Provide EV/S
for Glanbia PLC.

Provide EV/GP
for Glanbia PLC.

Provide EV/EBITDA
for Glanbia PLC.

Provide EV/EBIT
for Glanbia PLC.

Provide EV/OCF
for Glanbia PLC.

Provide EV/FCFF
for Glanbia PLC.

Provide EV/IC
for Glanbia PLC.

Show me price targets
for Glanbia PLC made by professional analysts.

What are the Revenue projections
for Glanbia PLC?

How accurate were the past Revenue estimates
for Glanbia PLC?

What are the Net Income projections
for Glanbia PLC?

How accurate were the past Net Income estimates
for Glanbia PLC?

What are the EPS projections
for Glanbia PLC?

How accurate were the past EPS estimates
for Glanbia PLC?

What are the EBIT projections
for Glanbia PLC?

How accurate were the past EBIT estimates
for Glanbia PLC?

Compare the revenue forecasts
for Glanbia PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Glanbia PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Glanbia PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Glanbia PLC compared to its peers.

Compare the P/E ratios
of Glanbia PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Glanbia PLC with its peers.

Analyze the financial leverage
of Glanbia PLC compared to its main competitors.

Show all profitability ratios
for Glanbia PLC.

Provide ROE
for Glanbia PLC.

Provide ROA
for Glanbia PLC.

Provide ROIC
for Glanbia PLC.

Provide ROCE
for Glanbia PLC.

Provide Gross Margin
for Glanbia PLC.

Provide Operating Margin
for Glanbia PLC.

Provide Net Margin
for Glanbia PLC.

Provide FCF Margin
for Glanbia PLC.

Show all solvency ratios
for Glanbia PLC.

Provide D/E Ratio
for Glanbia PLC.

Provide D/A Ratio
for Glanbia PLC.

Provide Interest Coverage Ratio
for Glanbia PLC.

Provide Altman Z-Score Ratio
for Glanbia PLC.

Provide Quick Ratio
for Glanbia PLC.

Provide Current Ratio
for Glanbia PLC.

Provide Cash Ratio
for Glanbia PLC.

What is the historical Revenue growth
over the last 5 years for Glanbia PLC?

What is the historical Net Income growth
over the last 5 years for Glanbia PLC?

What is the current Free Cash Flow
of Glanbia PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Glanbia PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Glanbia PLC

Current Assets 1.5B
Cash & Short-Term Investments 300.9m
Receivables 524.4m
Other Current Assets 647.4m
Non-Current Assets 2.6B
Long-Term Investments 167.5m
PP&E 611.1m
Intangibles 1.8B
Other Non-Current Assets 16.4m
Current Liabilities 905.4m
Accounts Payable 598m
Short-Term Debt 175.6m
Other Current Liabilities 131.8m
Non-Current Liabilities 989.1m
Long-Term Debt 856.6m
Other Non-Current Liabilities 132.5m
Efficiency

Earnings Waterfall
Glanbia PLC

Revenue
4.5B USD
Cost of Revenue
-3.3B USD
Gross Profit
1.2B USD
Operating Expenses
-831.8m USD
Operating Income
372.1m USD
Other Expenses
-78m USD
Net Income
294.1m USD

Free Cash Flow Analysis
Glanbia PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Glanbia has surpassed its expectations in the first half of 2023 with a 6.6% growth in constant currency, driving an upgrade in full-year adjusted earnings per share guidance from 7-11% to 12-15%, all in constant currency. This positive outcome also supports a 10% increase in the interim dividend. Specifically, the Global Performance Nutrition (GPN) delivered robust H1 results with branded like-for-like revenues up by 3.7%, and earnings climbing over 20% year-on-year. The main drivers were pricing, which grew by almost 11%, and the strong performance of Optimum Nutrition (ON), which saw a 16% growth. Despite a 7.2% decline in branded volume mainly due to SlimFast, the ON brand and international volume and pricing are doing well, setting up a positive future outlook. Furthermore, due to stronger than expected margin progression, GPN's full-year '23 margin guidance will be upgraded by an additional 100 basis points, from an initial range of 12.5%-13.5% to a new range of 13.5%-14.5%. The group's overall financial position remains robust, with a debt-to-EBITDA ratio under 1x, and investments continuing in key strategic areas like talent, marketing, and innovation. Revenue growth is anticipated to be at the lower end of the projected 5-7% range, primarily due to the weight management decline offsetting growth in other areas.

What is Earnings Call?
Fundamental Scores

GL9 Profitability Score
Profitability Due Diligence

Glanbia PLC's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROE
Positive Free Cash Flow
Positive Gross Profit
Positive ROE
48/100
Profitability
Score

Glanbia PLC's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

GL9 Solvency Score
Solvency Due Diligence

Glanbia PLC's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
67/100
Solvency
Score

Glanbia PLC's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GL9 Price Targets Summary
Glanbia PLC

Wall Street analysts forecast GL9 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GL9 is 21.15 EUR with a low forecast of 17.17 EUR and a high forecast of 27.3 EUR.

Lowest
Price Target
17.17 EUR
16% Upside
Average
Price Target
21.15 EUR
43% Upside
Highest
Price Target
27.3 EUR
85% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for GL9?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GL9 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Glanbia PLC Logo
Glanbia PLC

Country

Ireland

Industry

Food Products

Market Cap

3.9B EUR

Dividend Yield

0%

Description

Glanbia Plc engages in the manufacture and distribution of dairy and nutritional ingredients. The company is headquartered in Kilkenny, Kilkenny and currently employs 8,071 full-time employees. The firm operates through two segments: Glanbia Performance Nutrition and Glanbia Nutritionals. The firm's Glanbia Performance Nutrition segment includes performance nutrition products. Its products are sold through a range of channels, including specialty retail, the Internet and gyms in a range of formats, including powders, bars and ready-to-drink beverages. The firm's Glanbia Nutritionals segment provides nutritional solutions. The company manufactures and sells cheese, dairy and non-dairy nutritional ingredients and vitamin and mineral premixes targeting the market focus on health and nutrition.

Contact

KILKENNY
KILKENNY
Glanbia House, Ring Road
+353567772200.0
www.glanbia.com

IPO

1988-03-01

Employees

8 071

Officers

CFO & Executive Director
Mr. Mark A. Garvey
CEO & Executive Director
Mr. Hugh McGuire Dip Finance, M.Sc
Group Secretary & Head of Investor Relations
Mr. Liam Hennigan
Head of Corporate Communications
Ms. Martha Kavanagh
Chief Corporate Development Officer
Mr. Ian Doyle
Chief Human Resources Officer
Ms. Sue Sweem
Show More
Chief ESG & Corporate Affairs Officer
Mr. Michael Patten
Chief Operating Officer of Glanbia Nutritionals
Mr. Tom Tench
Chief Executive Officer of Glanbia Nutritionals
Mr. Brian Phelan B. Comm, FCA
Chief Executive of Glanbia Ingredients Ireland Limited
Mr. Jim Bergin
Show Less

See Also

Discover More
What is the Intrinsic Value of one GL9 stock?

The intrinsic value of one GL9 stock under the Base Case scenario is 18.58 EUR.

Is GL9 stock undervalued or overvalued?

Compared to the current market price of 14.75 EUR, Glanbia PLC is Undervalued by 21%.

Back to Top